Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.
about
How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors.The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials.Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery
P2860
Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Have dipeptidyl peptidase-4 in ...... ffect of stem-cell chemokines.
@en
Have dipeptidyl peptidase-4 in ...... ffect of stem-cell chemokines.
@nl
type
label
Have dipeptidyl peptidase-4 in ...... ffect of stem-cell chemokines.
@en
Have dipeptidyl peptidase-4 in ...... ffect of stem-cell chemokines.
@nl
prefLabel
Have dipeptidyl peptidase-4 in ...... ffect of stem-cell chemokines.
@en
Have dipeptidyl peptidase-4 in ...... ffect of stem-cell chemokines.
@nl
P2860
P921
P1476
Have dipeptidyl peptidase-4 in ...... effect of stem-cell chemokines
@en
P2093
Milton Packer
P2860
P2888
P356
10.1186/S12933-017-0648-X
P407
P5008
P577
2018-01-08T00:00:00Z
P6179
1100258741